UroGen Pharma URGN Enterprise value

Enterprise value at other companies

Bristol-Myers SquibbBMY

$152.27B+14.9%

PfizerPFE

$222.4B+9.2%

Johnson & JohnsonJNJ

$639.97B+60.7%

Merck & Co.MRK

$367.21B+59.3%

ImmunityBio, Inc.IBRX

$8.16B+187%

Aura Biosciences, Inc.AURA

$361.36M+31.6%

FAQ

What is UroGen Pharma's enterprise value?

UroGen Pharma (URGN) reported enterprise value of $1.91B in Q2 2026.

How has UroGen Pharma's enterprise value changed year-over-year?

UroGen Pharma's enterprise value increased by 185.1% year-over-year, from $670.39M to $1.91B.

What is the long-term trend for UroGen Pharma's enterprise value?

Over 5 years (2020 to 2025), UroGen Pharma's enterprise value has grown at a 25.8% compound annual growth rate (CAGR), from $353.85M to $1.12B.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.